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Abstract
Background: Fat embolism syndrome (FES) associated with acute lung injury (ALI) is a clinical condition following
long bone fracture. We have reported 14 victims due to ALI with FES. Our laboratory has developed an animal
model that produced fat emboli (FE). The major purpose of this study was to test whether neutrophil activation
with phorbol myristate acetate (PMA) and inhibition with sivelestat (SVT) exert protection on the lung.
Methods: The lungs of Sprague-Dawley rats were isolated and perfused. FE was produced by addition of corn oil
micelles into the lung perfusate. PMA and SVT were given simultaneously with FE. Parameters such as lung
weight/body weight ratio, LW gain, exhaled nitric oxide (NO), protein concentration in bronchoalveolar lavage
relating to ALI were measured. The neutrophil elastase (NE), myeloperoxidase, malondialdehyde and phopholipase
A2 activity were determined. We also measured the nitrate/nitrite, methyl guanidine (MG), and cytokines.
Pulmonary arterial pressure and microvascular permeability were assessed. Lung pathology was examined and
scored. The inducible and endothelial NO synthase (iNOS and eNOS) were detected.
Results: FE caused ALI and increased biochemical factors. The challenge also resulted in pulmonary hypertension and
increased microvascular permeability. The NE appeared to be the first to reach its peak at 1 hr, followed by other
factors. Coadministration with PMA exacerbated the FE-induced changes, while SVT attenuated the effects of FE.
Conclusions: The FE-induced lung changes were enhanced by PMA, while SVT had the opposite effect. Sivelestat,
a neutrophil inhibitor may be a therapeutic choice for patients with acute respiratory distress syndrome (ARDS)
following fat embolism.
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Background
Fat embolism syndrome (FES) is a serious clinical problem
in patients associated with long bone fracture [1-3].
Although the precise mechanisms of FES remain unclear,
intravasation of fat or fatty acids from broken long bones
and other sources is the primary cause leading to FES
[3,4]. In two clinical investigations, we have reported a
total of 14 cases who died of acute respiratory distress syn-
drome (ARDS) associated with FES [1,3]. The occurrence
of ARDS following FES suggests that the lung is one of the
target organs following intravasation of fat emboli [1-4].
In order to elucidate the possible mediators involved in
the ARDS associated with FES, we have developed an
animal model that produces fat embolism in anesthetized
rats. Intravenous administration of corn oil micelles
induces alveolar edema and hemorrhage. The pathologi-
cal changes are associated with fatty droplets and fibrin
thrombi in the lung, kidney and brain. The arteriolar
lumen is filled with fatty deposits. Hypoxia and hypercap-
nia ensue. Biochemical changes include increases in
plasma phospholipase A2, nitrate/nitrite, methyl guani-
dine and proinflammatory cytokines [5]. The animal
model has been used to study the protective effect of
N-Acetylcysteine [6], and the effects of inducible nitric
oxide synthase (iNOS) inhibitors and nitric oxide donors
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Activation and recruitment of neutrophil that lead to the
release of neutrophil elastase (NE) and other toxic media-
tors may play an initial role in the pathogenesis of ALI/
ARDS [8-10]. Accumulating evidence has indicated the
involvement of neutrophil activation and NE induced by
phorbol myristate acetate (PMA) and other agents [11-13].
Animal experimentation has demonstrated that sivelestat
(SVT), an inhibitor of NE attenuates ALI via reduction of
NE following lipopolysaccharide administration or inhala-
tion [14,15], and cardiopulmonary bypass [16,17].
The present study was designed to test whether neutro-
phil activation with PMA and inhibition with SVT exert
protective and/or detrimental effects on the acute lung
injury caused by fat embolism.
Materials and methods
Animal preparation
We used male Spague-Dawley (SD) rats, 12-14 wk-old,
weighing 360-380 g. The animals were obtained from the
National Animal Center and housed in the University
Laboratory Animal Center with good environment con-
trol. The animal experiment was approved by the Univer-
sity Committee of Laboratory Animal Care and Use, and
followed the guidelines of the National Animal Research
Center. The room temperature was maintained at 21 ±
1°C under a 12/12 hr light/dark regimen. Food and water
were provided ad libitum.
Isolation and perfusion of the lung in situ
We followed the procedures for the preparation of iso-
lated and perfused rat’sl u n g sin situ [ 7 , 1 8 ] .I nb r i e f ,t h e
rat’s lungs were isolated and perfused with constant flow.
Lung weight (LW) and LW gain (LWG) were recorded.
Pulmonary arterial pressure (PAP) and pulmonary
venous pressure (PVP) were measured.
Microvascular permeability (Kfc)
Capillary filtration coefficient (Kfc) as an index of micro-
vascular permeability was calculated from the increase
in LW produced by an elevation in PVP. The Kfc was
defined as the initial weight gain rate (g/min) divided by
PVP (10 cm H2O) and LW, and expressed as g/min/
cmH2O/100 g. During the experiment, PVP was rapidly
elevated by 10 cm H2O for 7 min to measure Kfc.T h i s
hydrostatic challenge elicited a biphasic increase in LW:
an initial rapid component, followed by slow and steady
component. The slow component of the weight gain
was plotted on a semilog scale as a function of time.
The capillary filtration rate was obtained by extrapolat-
ing the slow component of the weight gain back to zero
time [7,18].
Exhaled NO
An increase in exhaled NO concentration has been used
as an early marker of lung inflammation or injury [19,20].
We measured the NO concentration in expired air. A spe-
cimen of exhaled air (300 ml in 30 min) was suctioned
into a gas purge chamber previously evacuated to remove
oxygen. The NO concentration was rapidly determined
after air collection. The measurement of NO with a che-
miluminescence analyzer (Sievers 270B NOA; Sievers
Institute, Denver, CO, USA) was based on the principle
that NO interacts with ozone to generate chemilumines-
cent light. The chemiluminescence is directly proportional
to the NO level. In addition to a photomultiplier tube, an
ozone generator and a gas chamber were included. The
ozone generator was used to produce ozone internally.
The exhaled NO was measured every 30 min after intro-
duction of corn micelles into the lung perfusate. It reached
its peak depending on the experimental conditions. The
peak value was taken as the NO concentration.
Protein concentration in bronchoalveolar lavage (PCBAL)
After the experiment, lungs were lavaged twice with saline
(2.5 ml per lavage). Lavage samples were centrifuged at
1,500 g at room temperature for 10 min. The PCBAL was
determined with a spectrophotometer by measuring the
change in absorbance at 630 nm after the addition of bro-
mocresol green [6,20].
Neutrophil elastase, myeloperoxidase, malondialdehyde
and phospholipase A2 activity
The neutrophil elastase (NE) in lung perfusate was deter-
mined with a synthetic substrate, N-methoxysuccinyl-Ala-
Ala-Pro-Val-p-nitroanilide as described previously [6,11].
In brief, samples were incubated in 0.1 M Tris-HCl buffer
(pH 8.0) containing 0.5 M NaCl and 1 mM substrate at
37°C for 24 hr. After incubation, p-nitroanilide release was
measured spectrophotometrically at 450 nM and was con-
sidered NE activity.
To measure the myeloperoxidase (MPO) activity in
lung perfusate, the samples were mixed with 2 ml of
potassium phosphate buffer (50 mM, pH 6.0) containing
0.5% cetyltrimethylammonium bromide and were centri-
fuged at 2,500 g for 10 min at 4°C. The supernatant was
diluted with dilution buffer, then mixed with an assay
buffer composed of 0.00107% H2O2 in potassium phos-
phate buffer and o-dianisidine. The reaction mixture
was incubated at room temperature. The change in
absorbance at 450 nm over 1 min was detected spectro-
photometrically. The MPO activity was expressed as
units per ml of lung perfusate using the absorbance of
MPO standard (Elastine Products, Detroit, MC., USA).
The procedures were basically followed those by
Kinoshita et al. [8].
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turic acid reaction. The principle of the method depends
on the development of pink color produced by the
interaction of barbituric acid with MDA as a result of
lipid peroxidation. Tetraetoxypropane was used as stan-
dard [21,22].
Plasma concentrations of phospholipase A2 (PLA2)
were measured on a spectrofluorimeter using a method
described by Kitsiouli et al. [23]. In brief, the standard
incubation mixture contained 10 mmol/l tris/HCl buffer
(pH 7.4) with 2 mmol/l Ca2
+ and 5 μmil/l C12-NBD-PC
{1-palmitoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)
amino]hexanoyl]-sn-glycero-3-phosphocholine} as the
substrate. The absorbance of reaction mixture was mea-
sured with excitation and emission wavelengths at 475
and 535 nm, respectively.
Nitrate/nitrite, methyl guanidine, tumor necrosis factora
and interleukin-1b
Samples (0.5 ml) were taken from the lung perfusate 1 hr
before and at various time points after drug administra-
tion. The samples were centrifuged at 3,000 g for 10 min.
The supernatant was used for determination of nitrate/
nitrite with high-performance chromatography [20,24].
The formation of methyl guanidine (MG) has been identi-
fied as an index of hydroxyl radical production [6,25]. It
was determined with its fluorescence spectrum (Jasco 821-
FP, Spectroscopic Co., Tokyo, Japan). The emission maxi-
mum was set at 500 nm and the excitation maximum at
398 nm. The assay was calibrated with authentic MG
(Sigma M0377). Tumor necrosis factora (TNFa) and inter-
leukin-1b (IL-1b) were measured with antibody enzyme-
linked immunosorbent assays (ELISAs) with a commercial
antibody pair, recombinant standards, and a biotin-strep-
tavdin-peroxidase detection system (Endogen, Rockford,
IL, USA). All agents, samples, and working standards were
prepared at room temperature according to the manufac-
turer’s directions. The optical density was measured at
450/540 nm wavelengths by automated ELISA readers.
Lung pathology
Lung tissue was fixed in 10% formaldehyde for 24 hr and
then rinsed with tap water to remove formaldehyde. For
light microscopic examination, lung tissue was dehy-
drated with graded alcohol and then embedded in paraf-
fin at 60°C. A series of microsections (5 μm) was stained
with hematoxylin and eosin. For quantification of lung
injury score, we employed a modified grading method
reported previously [6,24,25]. Various degree of lung
injury score (LIS) were assessed as follows: degree 0, 1, 2,
and 3 for no, mild, moderate and severe edema, respec-
tively. For neutrophil and other cell infiltration, the scor-
ing was similar to the evaluation of edema formation,
degree 0-3 for no, mild, moderate and severe cellular
infiltration. The histopathological assessment was per-
formed in a blind fashion by several laboratory assistants.
Each one gave a score for edema and cell infiltration
from 0 to 3. The individual scores for edema and cell
infiltration were added together to obtain a final score,
ranging from 0-6.
Detection of iNOS and eNOS mRNA in lung tissue
Reverse-transcriptase polymerase chain reaction (RT-
PCR) was employed for a semiquantitative detection of
iNOS and eNOS mRNA expression [26].
Drugs
Phorbol myristate acetate (PMA) (Sigma Chemical, St
Louis, MO, USA) was dissolved in dimethyl sulfoxide
(DMSO; Sigma). Sivelestat (ONO-6818) was obtained
from ONO company, Japan. It was dissolved in distilled
water.
Experimental protocol
A total of 40 isolated lungs was randomly divided into 4
groups. The vehicle group received DMSO 100 μg/g lung
weight. In the FE group, corn oil 0.6 ml with distilled
water 0.2 ml was added into the lung perfusate [5,6]. The
FE+PMA group received corn oil micelles with PMA
(4 μg/g lung weight) [27,28]. Sivelestat (10 μg/g lung
weight) was coadministered with corn oil micelles in
FE+SVT group. The dose was based on the dosage range
from previous studies [29,30]. The isolated lungs were
observed for 3 hr.
Statistical analysis
All data were expressed as mean ± SEM. Comparisons
within and among groups as well as data measurements
over time in the same group were made using one-way
analysis of variance with repeated measures, followed a
post hoc comparison with Newman-Keuls test. Differ-
ences were considered to be statistically significant at
p < 0.05.
Results
LW/BW ratio, LWG, exhaled NO and PCBAL
In the isolated perfused lungs, FE caused ALI as evi-
denced by the increases in LW/BW ratio, LWG, exhaled
NO, and PCBAL (Figure 1). PAP and Kfc were markedly
elevated (Figure 2). Histopathological examination
revealed severe lung edema and hemorrhage with inflam-
matory cell infiltration (Figure 3). The LIS was greatly
larger than the vehicle control (Table 1). Biochemical
determinations demonstrated significant increases in NE,
MPO, MDA, PLA2, nitrate/nitrite, methyl guanidine,
TNFa,a n dI L - 1 b (Figures 4 and 5). The time course
demonstrated that NE reached it’s peak at 1 hr after FE,
MPO at 2 hr, MDA at 1.5 hr and PLA2 at 2 hr (Figure 4).
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tumor necrosis factora and interleukin-1b at 2 hr (Figure 5).
FE upregulated the iNOS expression significantly, while the
eNOS was modestly increased (Figures 6A and 6B).
Addition of PMA significantly exacerbated the ALI
induced by FE. The values of LW/BW, LWG, exhaled
NO, and PCBAL were elevated over those in the FE
group (Figure 1). PMA also aggravated the FE-induced
increases in pulmonary hypertension and capillary per-
meability (Figure 2). The lung pathology and LIS follow-
ing FE were largely exacerbated by PMA (Figure 3 and
Table 1). In addition, PMA aggravated the FE-induced
increases in NE, MPO, MDA and PLA2 activities (Figure
4). It also increased the nitrate/nitrite, methyl guanidine,
TNFa and IL-1b levels (Figure 5). This agent enhanced
the iNOS expression significantly, while it elevated the
eNOS mRNA modestly (Figure 6).
Administration of SVT significantly attenuated the FE-
induced changes in lung parameters including LW/BW,
LWG, exhaled NO, and PCBAL (Figure 1). It also
reduced the PAP level and microvascular permeability
(Figure 2). This neutrophil inhibitor abrogated the
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Page 4 of 11histopathological lesions of the lung and snignificantly
reduced the LIS (Figure 3 and Table 1). The NE, MPO,
MDA, PLA2, nitrate/nitrite, methyl guanidine, TNFa and
IL-1b in lung perfusate were decreased by SVT (Figures 4
and 5). The NE inhibitor attenuated the FE-induced
upregulation of iNOS significantly, whereas the eNOS
expression modestly (Figure 6).
Discussion
In the present study, we observed that fat embolism
caused severe lung injury as evidenced by the changes
in lung weight, exhaled NO, protein concentration in
bronchoalveolar lavage fluid. In isolated lungs, FE
caused severe lung injury associated with increases in
pulmonary arterial pressure and microvascular perme-
ability. The insult also resulted in increases in neutro-
phil elastase, myeloperoxidase, malondialdehyde and
phospholipase A2 activities. In addition, FE elevated the
nitrate/nitrite, methyl guanidine, tumor necrosis factora
and interleukin-1b in lung perfusate. These pulmonary
and biochemical changed were enhanced by coadminis-
tration with PMA, while mitigated by SVT.
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respiratory distress syndrome are complicated. Two clini-
cal investigations from our laboratory have suggested that
NO, phospholipase A2, free radicals and proinflammatory
cytokines are involved in the chemical phase. The major
source of NO is the alveolar macrophages [1,3]. Animal
studies have revealed that N-acetylcysteine and NO inhibi-
tors are able to abrogate the FE-induced changes [6,7].
D
A
C
B
Figure 3 Histopathology of the lung tissue in vehicle (A), FE (B), FE + PMA (C) and FE + SVT (D) groups. FE caused severe alveolar
edema and hemorrhage with inflammatory cell infiltration. Coadministration with PMA enhanced, but SVT diminished the lung pathology.
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that NE inhibitor, sivelestat may be a therapeutic consid-
eration for patients with FE syndrome.
Our observation of the time course of changes in media-
tors and proinflammatory cytokines may be valuable in
the identification of the pathological subsequence of fat
embolism. Neutrophil elastase may be released at the early
chemical phase, followed by malondialdehyde, NO and
hydroxyl radical (1.5 hr), then myeloperoxidase, phospho-
lipase A2, tumor necrosis factora and interleukin-1b (2 hr).
To verify this contention and identify the consequence of
inflammatory cascade following FE, further studies using
transgenic animals and specific inhibitors are required.
The physical phase of fat embolism syndrome caused
pulmonary hypertension and increased capillary perme-
ability because of pulmonary microvascular obstruction
[4,6]. We indeed observed two phases of increases in
PAP and LWG, an initial sharp upstroke followed by a
slow rise (not shown). The changes may reflect the early
physical phase and the late chemical phase of pulmonary
hypertension and increased Kfc.
The increases in exhaled NO and nitrate/nitrite in lung
perfusate, and NOS expression suggested that NO produc-
tion was involved in the FE-induced ALI and associated
changes. Our laboratory has reported that NO via the
iNOS up-regulation contributed to the development of
ARDS in children with enterovirus infection, patients with
leptospirosis and scrub tybus and animal with hypercalce-
mia and endotoxemia [31-34]. In a murine model of
Table 1 The lung injury score
Vehicle 0.06 ± 0.02
FE 2.86 ± 0.12*
FE + PMA 4.93 ± 0.22*
+
FE + SVT 1.42 ± 0.08*
+§
Values are mean ± SEM (n = 10 for each group). *p < 0.05 vs. Vehicle;
+p <
0.05 FE + PMA and FE + SVT groups vs. FE group;
§p < 0.05 FE + SVT vs. FE +
PMA. FE, fat embolism; PMA, phorbol myristate acetate; SVT, sivelestat.
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Figure 4 Time course of changes in neutrophil elastase (A), myeloperoxidase (B), malondialdehyde (C) and phospholipase A2 (D) in
lung perfusate of vehicle, FE, FE + PMA and FE + SVT groups.* p < 0.05 vs. vehicle;
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Page 7 of 11sepsis, Razava et al. proposed up-regulation of iNOS in the
lung caused neutrophil infiltration. The recruitment
iNOS-positive neutrophil further aggravated the oxidative
s t r e s si nt h el u n g[ 3 5 ] .W eh a v ea l s or e p o r t e dt h a tp r e -
treatment of iNOS isoform inhibitors attenuated the
inflammatory responses to endotoxin, fat embolism and
PMA. On the other hand, NO donors enhanced the
pathological and biochemical changes [7,27,36]. Accord-
ingly, NO production through the iNOS system plays a
detrimental role in endotoxemia, infections and fat embo-
lism as well. The participation of eNOS in the FE-induced
changes appears to be of less importance.
Neutrophil activation and recruitment leading to
release of neutrophil elastase, myeloperoxidase and mal-
ondialdehyde and other mediators have been proposed to
be a important step leading to an inflammatory cascade.
Pulmonary hypertension and increased microvascular
permeability ensued. These alterations finally resulted in
damage of the alveolar capillary barriers, thus created
severe lung injury [8,9,11]. In the present study, the
neutrophil-derived mediators were significantly elevated
following fat embolism. The facilitatory effects of phorbol
myristate acetate, while the inhibitory effects of sivelestat
on the pathophysiological, biochemical and molecular
changes induced by fat embolism further support the
importance of neutrophil activation and release of neu-
trophil-derived mediators on the acute lung injury
induced by fat embolism. In addition, phospholipase A2
was increased in bronchoalveolar fluid and plasma of
patients associated with fat embolism syndrome [2,3].
The ultimate role of phospholipase A2 in the FE-induced
acute lung injury requires further investigation.
Conclusions
Fat embolism caused acute lung injury, pulmonary hyper-
tension, increased microvascular permeability and lung
pathology. The challenge in isolated and perfused rat’s
lungs also significantly elevated the neutrophil elastatase,
myeloperoxidase, malondialdehyde and phopholipase A2
in lung perfusate. In addition, fat embolism caused
-1.5 -1.0 -0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
0
500
1000
1500
2000
2500
3000
3500
4000
§
§
§
§
§
+ + + +
+
* * * *
*
*
* * * *
*
* * * *
*
§
* +
A
Time (hr)
N
i
t
r
a
t
e
/
N
i
t
r
i
t
e
 
(
p
m
o
l
/
l
)
-1.5 -1.0 -0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
0
1
2
3
4
5
6
7
8
+ + + +
+
§ §
§ §
§
* * * *
* * *
*
*
* *
* *
*
*
*
+ *
§
 Vehicle (n=10)
 FE (n=10)
 FE+PMA (n=10)
 FE+SVT (n=10)
B
Time (hr)
M
e
t
h
y
l
 
G
u
a
n
i
d
i
n
e
 
(
m
m
o
l
/
l
)
-1.5 -1.0 -0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
0
500
1000
1500
2000
2500
3000
3500
4000
+ +
+
+
§
§
§
§ *
* *
*
*
*
* *
*
*
*
*
* * *
*
§
§
*+
C
Time (hr)
T
u
m
o
r
 
N
e
c
r
o
s
i
s
 
F
a
c
t
o
r
D
 
(
p
g
/
m
l
)
-1.5 -1.0 -0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
0
1000
2000
3000
4000
5000
6000
§
§
§
§
§
+ +
+
+
* *
*
*
*
*
*
*
*
* * * *
*
*
*
§
*+
D
I
n
t
e
r
l
e
u
k
i
n
-
1
E
 
(
p
g
/
m
l
)
Time (hr)
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changes in these mediators. *p < 0.05 vs. vehicle;
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Figure 6 Expression of inducible NO synthase (iNOS) and endothelial NO synthase (eNOS) mRNA by reverse transcriptase chain
reaction in various groups (A). The iNOS/GAPDH and eNOS/GAPDH ratios (B) were increased by FE (*p < 0.05). Coadministration with PMA
increased the iNOS and eNOS expression (
+p < 0.05), while SVT attenuated the mRNA expression of iNOS and eNOS (
§p < 0.05).
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Page 9 of 11release of nitrate/nitrite, hydroxyl radical, tumor necrosis
factora and interleukin-1b f r o mt h el u n g .T h et i m e
course revealed that neutrophil elastase was produced at
the early chemical phase followed by other mediators.
NO production through the iNOS exerts a detrimental
effect on the lungs. Cotreatment with phorbol myristate
acetate (a neutrophil elastase activator) exacerbated,
while sivelestat (a neutrophil elastase inhibitor) attenu-
ated the FE-induced changes. Neutrophil activation and
neutrophil-derived mediators are involved in the FE syn-
drome associated with acute lung injury. Sivelestat may
be recommended for clinical application in subjects with
fat embolism syndrome.
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